scholarly article | Q13442814 |
P50 | author | Juan C Montero | Q56811309 |
Ricardo López-Pérez | Q74673991 | ||
Atanasio Pandiella | Q83446572 | ||
Jesús San Miguel | Q5930658 | ||
P433 | issue | 6 | |
P921 | main subject | multiple myeloma | Q467635 |
P304 | page(s) | 851-859 | |
P577 | publication date | 2008-04-28 | |
P1433 | published in | Haematologica | Q5638209 |
P1476 | title | Expression of c-Kit isoforms in multiple myeloma: differences in signaling and drug sensitivity | |
P478 | volume | 93 |
Q39650027 | A meta-analysis of prognostic value of KIT mutation status in gastrointestinal stromal tumors |
Q38190971 | Association of Chromosomal Translocation and MiRNA Expression with The Pathogenesis of Multiple Myeloma |
Q41360812 | Autocrine insulin-like growth factor 1 and stem cell factor but not interleukin 6 support self-renewal of human myeloma cells |
Q34543082 | CD117 expression in gammopathies is associated with an altered maturation of the myeloid and lymphoid hematopoietic cell compartments and favorable disease features |
Q92669995 | Clinical prognostic implications of EPB41L4A expression in multiple myeloma |
Q35058356 | Discovery and development of small molecule SHIP phosphatase modulators |
Q36959863 | Emerging functions of c-kit and its ligand stem cell factor in dendritic cells: regulators of T cell differentiation |
Q34924515 | High-resolution kinetics of cytokine signaling in human CD34/CD117-positive cells in unfractionated bone marrow |
Q38641261 | Immunophenotype of normal and myelomatous plasma-cell subsets |
Q37276382 | KIT GNNK splice variants: expression in systemic mastocytosis and influence on the activating potential of the D816V mutation in mast cells |
Q37340398 | New targets and treatments in multiple myeloma: Src family kinases as central regulators of disease progression |
Q33416297 | Recent advances in antimultiple myeloma drug development |
Q36811035 | Signaling of c-kit in dendritic cells influences adaptive immunity |
Q38922393 | The Assessment of CD56 and CD117 Expressions at the Time of the Diagnosis in Multiple Myeloma Patients |
Q38264052 | The SCF/c-KIT system in the male: Survival strategies in fertility and cancer |
Q37641380 | The role of ancestim (recombinant human stem-cell factor, rhSCF) in hematopoietic stem cell mobilization and hematopoietic reconstitution |
Q39401758 | The stem cell factor (SCF)/c-KIT signalling in testis and prostate cancer |
Q35718988 | Therapeutic potential of SH2 domain-containing inositol-5'-phosphatase 1 (SHIP1) and SHIP2 inhibition in cancer |
Q44004521 | Transcriptomic rationale for the synergy observed with dasatinib + bortezomib + dexamethasone in multiple myeloma |
Search more.